Features
RSV-Naïve Infants Pose a Challenge to RSV Vaccine Development
The hunt is on for a vaccine against deadly respiratory syncytial virus (RSV), but a poor understanding of the molecular mechanisms of infection and acquired immunity have slowed vaccine research and development.